91 related articles for article (PubMed ID: 20478328)
1. Olanzapine affects locomotor activity and meal size in male rats.
van der Zwaal EM; Luijendijk MC; Evers SS; la Fleur SE; Adan RA
Pharmacol Biochem Behav; 2010 Nov; 97(1):130-7. PubMed ID: 20478328
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats.
Evers SS; Calcagnoli F; van Dijk G; Scheurink AJ
Pharmacol Biochem Behav; 2010 Nov; 97(1):163-9. PubMed ID: 20570692
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution.
van der Zwaal EM; Luijendijk MC; Adan RA; la Fleur SE
Eur J Pharmacol; 2008 May; 585(1):130-6. PubMed ID: 18378227
[TBL] [Abstract][Full Text] [Related]
5. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
Davoodi N; Kalinichev M; Korneev SA; Clifton PG
Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
[TBL] [Abstract][Full Text] [Related]
6. Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats.
Victoriano M; Hermier D; Even PC; Fromentin G; Huneau JF; Tomé D; de Beaurepaire R
Psychopharmacology (Berl); 2009 Sep; 206(1):167-76. PubMed ID: 19572122
[TBL] [Abstract][Full Text] [Related]
7. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats.
Shobo M; Yamada H; Koakutsu A; Hamada N; Fujii M; Harada K; Ni K; Matsuoka N
Life Sci; 2011 Apr; 88(17-18):761-5. PubMed ID: 21356217
[TBL] [Abstract][Full Text] [Related]
9. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
[TBL] [Abstract][Full Text] [Related]
10. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
Fell MJ; Marshall KM; Williams J; Neill JC
J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
[TBL] [Abstract][Full Text] [Related]
11. The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature.
van der Zwaal EM; Merkestein M; Lam YK; Brans MA; Luijendijk MC; Bok LI; Verheij ER; la Fleur SE; Adan RA
Int J Obes (Lond); 2012 Feb; 36(2):254-61. PubMed ID: 21556042
[TBL] [Abstract][Full Text] [Related]
12. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
Deng C; Lian J; Pai N; Huang XF
J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance.
Guesdon B; Denis RG; Richard D
Behav Brain Res; 2010 Feb; 207(1):14-20. PubMed ID: 19788900
[TBL] [Abstract][Full Text] [Related]
14. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
[TBL] [Abstract][Full Text] [Related]
15. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
Lazzari P; Serra V; Marcello S; Pira M; Mastinu A
Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074
[TBL] [Abstract][Full Text] [Related]
16. Timing of fat and liquid sugar intake alters substrate oxidation and food efficiency in male Wistar rats.
Oosterman JE; Foppen E; van der Spek R; Fliers E; Kalsbeek A; la Fleur SE
Chronobiol Int; 2015 Mar; 32(2):289-98. PubMed ID: 25317718
[TBL] [Abstract][Full Text] [Related]
17. Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.
Mann S; Chintoh A; Giacca A; Fletcher P; Nobrega J; Hahn M; Remington G
Pharmacol Biochem Behav; 2013 Feb; 103(4):717-22. PubMed ID: 23234835
[TBL] [Abstract][Full Text] [Related]
18. A parametric analysis of olanzapine-induced weight gain in female rats.
Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in rats.
Muller AP; Tort AH; Gnoatto J; Moreira JD; Vinadé ER; Perry ML; Souza DO; Lara DR; Portela LV
Behav Pharmacol; 2010 Oct; 21(7):668-75. PubMed ID: 20729714
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats.
Weston-Green K; Huang XF; Deng C
Behav Brain Res; 2011 Mar; 217(2):337-46. PubMed ID: 21056063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
